215 related articles for article (PubMed ID: 19171763)
1. Antibody to the dendritic cell surface activation antigen CD83 prevents acute graft-versus-host disease.
Wilson J; Cullup H; Lourie R; Sheng Y; Palkova A; Radford KJ; Dickinson AM; Rice AM; Hart DN; Munster DJ
J Exp Med; 2009 Feb; 206(2):387-98. PubMed ID: 19171763
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppressive human anti-CD83 monoclonal antibody depletion of activated dendritic cells in transplantation.
Seldon TA; Pryor R; Palkova A; Jones ML; Verma ND; Findova M; Braet K; Sheng Y; Fan Y; Zhou EY; Marks JD; Munro T; Mahler SM; Barnard RT; Fromm PD; Silveira PA; Elgundi Z; Ju X; Clark GJ; Bradstock KF; Munster DJ; Hart DN
Leukemia; 2016 Mar; 30(3):692-700. PubMed ID: 26286117
[TBL] [Abstract][Full Text] [Related]
3. Human CD83-targeted chimeric antigen receptor T cells prevent and treat graft-versus-host disease.
Shrestha B; Walton K; Reff J; Sagatys EM; Tu N; Boucher J; Li G; Ghafoor T; Felices M; Miller JS; Pidala J; Blazar BR; Anasetti C; Betts BC; Davila ML
J Clin Invest; 2020 Sep; 130(9):4652-4662. PubMed ID: 32437331
[TBL] [Abstract][Full Text] [Related]
4. CD83 Antibody Inhibits Human B Cell Responses to Antigen as well as Dendritic Cell-Mediated CD4 T Cell Responses.
Wong KY; Baron R; Seldon TA; Jones ML; Rice AM; Munster DJ
J Immunol; 2018 May; 200(10):3383-3396. PubMed ID: 29643191
[TBL] [Abstract][Full Text] [Related]
5. Daratumumab Prevents Experimental Xenogeneic Graft-Versus-Host Disease by Skewing Proportions of T Cell Functional Subsets and Inhibiting T Cell Activation and Migration.
Gao Y; Shan W; Gu T; Zhang J; Wu Y; Li X; Zeng X; Zhou H; Chen Z; Xiao H
Front Immunol; 2021; 12():785774. PubMed ID: 34987512
[TBL] [Abstract][Full Text] [Related]
6. TIGIT-Fc alleviates acute graft-versus-host disease by suppressing CTL activation via promoting the generation of immunoregulatory dendritic cells.
Zhang D; Hu W; Xie J; Zhang Y; Zhou B; Liu X; Zhang Y; Su Y; Jin B; Guo S; Zhuang R
Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):3085-3098. PubMed ID: 29960041
[TBL] [Abstract][Full Text] [Related]
7. The Analysis of CD83 Expression on Human Immune Cells Identifies a Unique CD83+-Activated T Cell Population.
Ju X; Silveira PA; Hsu WH; Elgundi Z; Alingcastre R; Verma ND; Fromm PD; Hsu JL; Bryant C; Li Z; Kupresanin F; Lo TH; Clarke C; Lee K; McGuire H; Fazekas de St Groth B; Larsen SR; Gibson J; Bradstock KF; Clark GJ; Hart DN
J Immunol; 2016 Dec; 197(12):4613-4625. PubMed ID: 27837105
[TBL] [Abstract][Full Text] [Related]
8. NK026680, a novel compound suppressive of dendritic cell function, ameliorates mortality in acute lethal graft-versus-host reaction in mice.
Saiga K; Toyoda E; Tokunaka K; Masuda A; Matsumoto S; Mashiba H; Kuramochi H; Nemoto K; Abe F; Kawagishi N; Furukawa H; Ono M
Bone Marrow Transplant; 2006 Feb; 37(3):317-23. PubMed ID: 16299543
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Human Dendritic Cell ER Stress Response Reduces T Cell Alloreactivity Yet Spares Donor Anti-tumor Immunity.
Betts BC; Locke FL; Sagatys EM; Pidala J; Walton K; Menges M; Reff J; Saha A; Djeu JY; Kiluk JV; Lee MC; Kim J; Kang CW; Tang CH; Frieling J; Lynch CC; List A; Rodriguez PC; Blazar BR; Conejo-Garcia JR; Del Valle JR; Hu CC; Anasetti C
Front Immunol; 2018; 9():2887. PubMed ID: 30574153
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of graft-versus-host-disease in NOD scid IL-2Rγ(-/-) (NSG) mice by ex vivo modulation of human CD4(+) T cells.
Hilger N; Glaser J; Müller C; Halbich C; Müller A; Schwertassek U; Lehmann J; Ruschpler P; Lange F; Boldt A; Stahl L; Sack U; Oelkrug C; Emmrich F; Fricke S
Cytometry A; 2016 Sep; 89(9):803-15. PubMed ID: 27560708
[TBL] [Abstract][Full Text] [Related]
11. Prevention of acute graft-versus-host disease in a xenogeneic SCID mouse model by the humanized anti-CD74 antagonistic antibody milatuzumab.
Chen X; Chang CH; Stein R; Cardillo TM; Gold DV; Goldenberg DM
Biol Blood Marrow Transplant; 2013 Jan; 19(1):28-39. PubMed ID: 23025988
[TBL] [Abstract][Full Text] [Related]
12. Programming of donor T cells using allogeneic δ-like ligand 4-positive dendritic cells to reduce GVHD in mice.
Mochizuki K; Meng L; Mochizuki I; Tong Q; He S; Liu Y; Purushe J; Fung H; Zaidi MR; Zhang Y; Reshef R; Blazar BR; Yagita H; Mineishi S; Zhang Y
Blood; 2016 Jun; 127(25):3270-80. PubMed ID: 27143255
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic T lymphocyte antigen-4 regulates development of xenogenic graft versus host disease in mice via modulation of host immune responses induced by changes in human T cell engraftment and gene expression.
Gao C; Gardner D; Theobalds MC; Hitchcock S; Deutsch H; Amuzie C; Cesaroni M; Sargsyan D; Rao TS; Malaviya R
Clin Exp Immunol; 2021 Dec; 206(3):422-438. PubMed ID: 34487545
[TBL] [Abstract][Full Text] [Related]
14. Generation of CD4+ cytotoxic T-lymphocyte clones from a patient with severe graft-versus-host disease after allogeneic bone marrow transplantation: implications for graft-versus-leukemia reactivity.
Faber LM; van Luxemburg-Heijs SA; Veenhof WF; Willemze R; Falkenburg JH
Blood; 1995 Oct; 86(7):2821-8. PubMed ID: 7670118
[TBL] [Abstract][Full Text] [Related]
15. The effect of human IL-2-activated natural killer and T cells on graft-versus-host disease and graft-versus-leukemia in SCID mice bearing human leukemic cells.
Xun CQ; Thompson JS; Jennings CD; Brown SA
Transplantation; 1995 Oct; 60(8):821-7. PubMed ID: 7482742
[TBL] [Abstract][Full Text] [Related]
16. Anti-CD3 preconditioning separates GVL from GVHD via modulating host dendritic cell and donor T-cell migration in recipients conditioned with TBI.
Li N; Chen Y; He W; Yi T; Zhao D; Zhang C; Lin CL; Todorov I; Kandeel F; Forman S; Zeng D
Blood; 2009 Jan; 113(4):953-62. PubMed ID: 18922852
[TBL] [Abstract][Full Text] [Related]
17. Membrane-bound and soluble porcine CD83 functions antithetically in T cell activation and dendritic cell differentiation in vitro.
Huo S; Zhang J; Liang S; Wu F; Zuo Y; Cui D; Zhang Y; Zhong Z; Zhong F
Dev Comp Immunol; 2019 Oct; 99():103398. PubMed ID: 31121186
[TBL] [Abstract][Full Text] [Related]
18. Human T lymphoblasts and activated dendritic cells in the allogeneic mixed leukocyte reaction are susceptible to NK cell-mediated anti-CD83-dependent cytotoxicity.
Munster DJ; MacDonald KP; Kato M; Hart DJ
Int Immunol; 2004 Jan; 16(1):33-42. PubMed ID: 14688058
[TBL] [Abstract][Full Text] [Related]
19. Ligation of OX40 (CD134) regulates graft-versus-host disease (GVHD) and graft rejection in allogeneic bone marrow transplant recipients.
Blazar BR; Sharpe AH; Chen AI; Panoskaltsis-Mortari A; Lees C; Akiba H; Yagita H; Killeen N; Taylor PA
Blood; 2003 May; 101(9):3741-8. PubMed ID: 12521997
[TBL] [Abstract][Full Text] [Related]
20. A model of human anti-T-cell monoclonal antibody therapy in SCID mice engrafted with human peripheral blood lymphocytes.
Tsuchida M; Brown SA; Tutt LM; Tan J; Seehafer DL; Harris JP; Xun CQ; Thompson JS
Clin Transplant; 1997 Oct; 11(5 Pt 2):522-8. PubMed ID: 9361954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
